Related Experiment Video
Updated: Jun 21, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif
Bizhan Romani1, Susan Engelbrecht, Richard H Glashoff
1Division of Medical Virology, Department of Pathology, University of Stellenbosch, Tygerberg Campus, Tygerberg, South Africa. Bizhan@sun.ac.za
Abstract:
Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like (APOBEC) proteins are members of a protein family sharing the common characteristic of cytidine deaminase activity. The antiviral activity of APOBEC3G and APOBEC3F has been studied more extensively than that of the other members of this family. The antiviral activity of APOBEC3B and APOBEC3DE has also been described. Studies of other APOBEC proteins have not revealed any antiviral activities against HIV-1; however, further investigation is required. In the absence of human immunodeficiency virus type 1 (HIV-1) virion infectivity factor (Vif), APOBEC3G and APOBEC3F are incorporated into HIV-1 virions and hypermutate the viral genomic DNA by their cytidine deaminase activity. HIV-1 Vif protein suppresses the antiviral role of APOBEC proteins by several mechanisms that lead to inhibition of incorporation of APOBEC3G/3F into HIV-1 virions. The detailed mechanisms involved in the suppression of APOBEC proteins by Vif are still being elucidated. Novel studies in which as yet undefined aspects of the suppression of APOBEC proteins are investigated could reveal important and potentially exploitable information for addressing HIV-1 infection in humans.
Insights
Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like (APOBEC) proteins exhibit antiviral properties against HIV-1 by hypermutating viral DNA. However, HIV-1 Vif protein suppresses this activity, and further research into these mechanisms could yield new therapeutic strategies.
Area of Science:
- Biochemistry
- Virology
- Molecular Biology
Background:
- APOBEC proteins possess cytidine deaminase activity and some exhibit antiviral properties.
- APOBEC3G and APOBEC3F are known to inhibit HIV-1 replication by hypermutating viral DNA in the absence of HIV-1 Vif.
- The mechanisms by which HIV-1 Vif suppresses APOBEC proteins are not fully understood.
Purpose of the Study:
- To review the antiviral activities of APOBEC proteins against HIV-1.
- To discuss the mechanisms of HIV-1 Vif-mediated suppression of APOBEC proteins.
- To highlight the need for further research into APOBEC-Vif interactions for potential therapeutic development.
Main Methods:
- Literature review of studies on APOBEC proteins and HIV-1.
- Analysis of the known antiviral functions of APOBEC family members.
- Examination of the molecular mechanisms of HIV-1 Vif antagonism.
Main Results:
- APOBEC3G and APOBEC3F are incorporated into HIV-1 virions and hypermutate viral DNA, inhibiting infectivity.
- HIV-1 Vif protein counteracts APOBEC activity by preventing their incorporation into virions.
- While some APOBECs show antiviral activity, others require further investigation.
Conclusions:
- APOBEC proteins are a crucial host defense mechanism against HIV-1.
- Understanding Vif's suppression of APOBECs is key to developing novel anti-HIV therapies.
- Further research into APOBEC-Vif interactions may uncover exploitable targets for combating HIV-1 infection.
More Related Videos
06:02Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
Published on: September 13, 2018
08:33Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors
Retroviruses
Retrovirus Life Cycles